Monthly Archives: July 2012

Lame dogs brought to heal with stem cells

Posted: Published on July 29th, 2012

Stem cell injections in dogs will become routine in the next two years and will probably cost less than $1000. The first data, collated last week, into the use of the procedure where cultured cells are injected into the joints of dogs with hip dysplasia or canine osteoarthritis has shown a success rate of 96 per cent. The procedure will be made available to veterinary clinics, promoted at dog shows and possibly in a television campaign. It has been transformed in little more than a year with stem cells from one animal used to treat other dogs. Previously, an invasive procedure was necessary, with incisions to remove subcutaneous or fatty tissue from the affected dog and stem cells isolated in a laboratory before being injected back into the dog. The procedure resulted in a culture containing only about 10 per cent to 15 per cent stem cells, while the culture from a donor in a breed with a genetic line clear of arthritis can been screened to provide a culture containing 100 per cent stem cells. The figures were collected from vets by Australian Veterinary Stem Cells, which supplies stem cell treatments and has a partnership with the immunology and … Continue reading

Posted in Stem Cell Injections | Comments Off on Lame dogs brought to heal with stem cells

Medical Megatrends – Stem Cells – Part II of III

Posted: Published on July 28th, 2012

Imagine a man with a recent severe heart attack who has the muscle repaired with stem cells or a child with a severe bladder defect repaired with stem cells grown on a biodegradable scaffold. Sounds like science fiction but these are actual clinical studies in progress today. Stem cell therapies promise to be one of those scientific breakthroughs that will have an enormous impact on health care in the future. Stem cells will bring us closer to the goal of personalized medicine, just as genomics is doing. The course of a disease will change once we have the technology to develop and then insert stem cells into the human body to actually create a tissue. For example, a person with a heart attack will not go on to live the rest of his or her life with damaged heart muscle and resultant heart failure. Instead, stem cells will repopulate the heart muscle and make it whole again. Similarly, a person with Parkinsons disease will recover full faculties thanks to the ability of stem cells to regenerate the damaged area of the brain. The person with type I diabetes will be free of the disease because of the formation of new … Continue reading

Posted in Mesenchymal Stem Cells | Comments Off on Medical Megatrends – Stem Cells – Part II of III

Jamie’s dad to be stem cells donor

Posted: Published on July 28th, 2012

Father of Jamie Inglis to be stem cells donor 9:37am Saturday 28th July 2012 in News By Kate Liptrot, kate.liptrot@thepress.co.uk THE father of a six-year-old boy bravely fighting cancer is likely to be a stem cell donor for medical treatment which could potentially save his life. Jamie Inglis has a 75 per cent chance of survival if he successfully goes through a clinical trial in Germany, according to his oncologist at Leeds General Infirmary, an expert on neuroblastoma. This form of cancer is so aggressive that treatment in the UK is inadequate and will prolong Jamies life only for months, so his family are in the process of raising 250,000 to fund the treatment. They have currently raised about 80,000. Jamies parents, John and Vicky, of Kelfield, near Selby , have been tested to see who would be the most appropriate donor. John has been chosen by the experts because he has the best properties to assist Jamies immune system, which does not recognise cancer cells. He is due to travel to Germany in early August, when he will have tests to detect any defects and to clarify that he can definitely be a donor. Mr Inglis said: We are … Continue reading

Comments Off on Jamie’s dad to be stem cells donor

Stem cells for neck injury: $20 million

Posted: Published on July 28th, 2012

Stem cells for neck injury: $20 million July 27th, 2012, 3:45 pm posted by Pat Brennan, science, environment editor Human neural stem cell. Image courtesy StemCells Inc. The states stem-cell institute has awarded $20 million to UC Irvine researchers, along with a private company, to prepare the way for human testing of a treatment for spinal-cord injuries in the neck region one that could restore movement and independence for some of the 1.3 million spinal-cord injury sufferers in the United States. The treatment, developed by the husband and wife research team, Aileen Anderson and Brian Cummings, along with StemCells Inc. of Newark, Ca., would involve injecting versatile human neural stem cells into the neck area. The cells, capable of transforming themselves based on cues from the body, could then migrate to the injured area and perhaps repair the protective sheaths, known as myelin, around nerve cells. If the treatment works as expected, it would restore movement and body control for patients with debilitating injuries. While the treatment has the potential to allow the paralyzed to walk again, more modest gains are more likely and well worth the effort, Anderson said Friday. UC Irvine husband-wife research team, Brian Cummings and Aileen … Continue reading

Comments Off on Stem cells for neck injury: $20 million

Amarin stroke drug wins approval

Posted: Published on July 28th, 2012

irishtimes.com - Last Updated: Friday, July 27, 2012, 10:08 Irish drug company Amarin has won US approval for its first drug, a treatment to help combat high levels of blood fat that can lead to stroke and heart attack. The Food and Drug Administration last night cleared Vascepa as an adjunct to diet for a condition known as very high triglycerides, the company said in a statement. The medication will compete with GlaxoSmithKline's Lovaza. Amarin anticipates starting sales in the first quarter of 2013, chief executive Joseph Zakrzewski said in the statement. Vascepa may have an advantage because it doesn't raise bad cholesterol levels, a possible side effect for Lovaza, Jon Lecroy, an analyst with MKM Partners in Stamford, Connecticut, said in an interview. Amarin's drug has the potential to reach sales of $1.25 billion in 2017, which may lead to acquisition offers for the Dublin-based company from drugmakers including AstraZeneca, Mr Lecroy said ahead of the approval. "There will be interest from large pharmaceutical companies," Mr Lecroy said. "Any company with a large cardiovascular or diabetes sales force makes sense. That's almost any." AstraZeneca, based in London, may be an option because of its best-selling cholesterol medication Crestor, Lecroy … Continue reading

Comments Off on Amarin stroke drug wins approval

Stroke victim receives treatment in China

Posted: Published on July 28th, 2012

A trip to China this spring to work out some of his physical disabilities due to a stroke was deemed a success by Marshalltown's Gary Septer. Septer spent 90 days in Tianjin, China, where he received acupuncture, aroma therapy, herbal soaks, electronic stimulation and other methods used by Chinese doctors to help stroke victims regain strength. Septer, 64, got some movement back in his right hand but not his right arm and got more feeling back in his arms and legs. "It went surprisingly good," Septer said. "The whole staff and all the doctors make you feel really welcome." They also put him on a diet where he was able to get off his diabetes and blood pressure medication. He spent his first six weeks in the hospital before he was finally given a chance to experience the sites of China. "They loaded us up one Sunday and took us to The Great Wall," Septer said. Gary said the doctors in China were looking to heal the whole person. "They don't just treat the symptoms," he said. When he returned in the spring he did suffer one setback - a bout with pneumonia one day after he was back in … Continue reading

Comments Off on Stroke victim receives treatment in China

Hospital demonstrates stroke treatment system

Posted: Published on July 28th, 2012

Reading Eagle The Pennsylvania Primary Stroke Center Recognition Act goes into effect today and to mark the occasion St. Joseph Medical Center officials Friday demonstrated new technology being used to treat stroke victims. The act, co-sponsored by State Rep. Thomas R. Caltagirone, a Reading Democrat, establishes a statewide network of certified primary stroke centers. It also calls for local emergency personnel to develop protocols so that stroke patients can immediately be taken to the nearest primary stroke center. Both St. Joseph and Reading Hospital are designated primary stroke centers in Berks County. "The act will assure that patients experiencing stroke symptoms will be quickly identified and transported to facilities that ensure the rapid triage, diagnostic evaluation and treatment of patients suffering a stroke," said Michael A. Jupina, vice president of marketing and communications at St. Joseph. In addition to recognizing Caltagirone for his work on passing the bill, staff of St. Joseph and Hershey Medical Center demonstrated LionNet, a system that uses real-time remote audio-visual technology to conduct consults with stroke neurologists or neurosurgeons from the Hershey hospital. Continued here: Hospital demonstrates stroke treatment system … Continue reading

Comments Off on Hospital demonstrates stroke treatment system

InVivo Therapeutics Announces New Stock Symbol ‘NVIV’

Posted: Published on July 28th, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and neurotrauma, announced today that the trading symbol for its stock, trading on the OTC Bulletin Board, has been changed from NVIV.OB to NVIV. The OTC Markets, which is the electronic quotation system for all OTC securities, has dropped .OB and .PK from the stock quote information it provides to online financial portals. Investors seeking stock quote information from online financial portals should now use simply NVIV to obtain a quote. We have received numerous questions regarding our stock price being stuck at $2.20 per share for the last few weeks as that was the last price of the stock under the old trading symbol, said InVivo Therapeutics CEO Frank Reynolds. Please refresh your symbols in your watch lists or portfolios to obtain an accurate price. This change in the trading symbol has no negative impact on InVivos continued successful performance. Corporate achievements include: About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed from traumatic spinal cord injuries. The company was founded in 2005 based … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics Announces New Stock Symbol ‘NVIV’

StemCells, Inc. Awarded $20 Million From the California Institute for Regenerative Medicine

Posted: Published on July 28th, 2012

Award to Fund IND-Enabling Activities for the Company's HuCNS-SC(R) Neural Stem Cells in Cervical Spinal Cord Injury Decision on Funding Alzheimer's Program Deferred to CIRM's September Board Meeting NEWARK, Calif., July 26, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (STEM) today announced that the California Institute for Regenerative Medicine (CIRM) has approved an award to the Company and its collaborators for up to $20 million under CIRM's Disease Team Therapy Development Award program (RFA 10-05). The award is to fund preclinical development of StemCells' proprietary HuCNS-SC(R) product candidate (purified human neural stem cells) as a potential treatment for cervical spinal cord injury. The award will provide funding over a maximum four-year period, with the goal of filing an investigational new drug (IND) application to begin clinical testing in that time. CIRM deferred a decision on the Alzheimer's disease application submitted by StemCells and referred the application back to CIRM's Grants Working Group for further consideration. CIRM is expected to review the application again at the next meeting of its governing board currently scheduled for September 6th. "We understand that this was a very competitive process and we are extremely grateful to CIRM for its support," commented Martin McGlynn, President and CEO … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on StemCells, Inc. Awarded $20 Million From the California Institute for Regenerative Medicine

Man diagnosed with brain tumor finds hope in alternative treatment

Posted: Published on July 28th, 2012

Readmore: Local, Community, Health, News, National, Robert Hockings, Skull Base Institute, Brain Tumor, Operation, Surgery, Baraga, Hrayr Shahinian BARAGA -- When Robert Hockings was diagnosed with a brain tumor, he feared for the worst. "I thought, '55 years isn't too bad, I've lived a good life so far it's probably coming to an end,'" recalled Hockings. Hockings works as a corrections officer at the Baraga Maximum Correctional Facility and it's there where an incident triggered a series of events that lead to his diagnosis. Back in May Hockings suffered a blow to the head during an inmate altercation at the prison. Hockings says that moment ended up changing his life. Hockings only thought he suffered a concussion, but severe and constant head-aches brought him back to the hospital. A CT scan revealed a mass growing near his brain and Hockings was rushed to Marquette General where he was diagnosed him with the tumor. He consulted with doctors at the Mayo Clinic, who recommended a heavily invasive procedure. "Their procedure there at Mayo in Rochester would be an open craniotomy where they cut you ear to ear, peel your face down and take a large portion of your skull cap off … Continue reading

Posted in Brain Injury Treatment | Comments Off on Man diagnosed with brain tumor finds hope in alternative treatment